Compare XBIT & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
| Metric | XBIT | GHG |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 119.1M |
| IPO Year | 2015 | 2017 |
| Metric | XBIT | GHG |
|---|---|---|
| Price | $2.37 | $1.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.1K | ★ 29.6K |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.02 |
| Revenue Next Year | N/A | $8.26 |
| P/E Ratio | ★ N/A | $5.76 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $1.11 |
| 52 Week High | $3.61 | $2.78 |
| Indicator | XBIT | GHG |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 46.97 |
| Support Level | $2.26 | $1.16 |
| Resistance Level | $2.69 | $1.32 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 10.34 | 34.82 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.